Group 1 - The sale of the P&HS business is now definitive, although it still requires closure and is subject to FTC review, indicating increased certainty around the transaction [1] - The company has transitioned to a pure-play Patient Direct business, which will allow for a more focused operational strategy and capital allocation [2] - With the constraints from the P&HS business removed, the company can now invest more aggressively in technology, sales, and product categories to accelerate growth [2]

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation. Why Is Ardent being Investigated for Securities Violations? Ardent is a provider of healthcare in mid-sized urban communitie ...

Core Insights - Five stocks have been added to the Zacks Rank 1 (Strong Buy) List, indicating strong potential for investment Group 1: Company Earnings Estimates - Kennametal Inc. (KMT) has seen a 25% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Universal Health Services, Inc. (UHS) has experienced a 6.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - WisdomTree, Inc. (WT) has reported a 6.8% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - Oceaneering International, Inc. (OII) has seen an 11.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - MediaAlpha, Inc. (MAX) has experienced a significant 700% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [3]

Core Insights - Three stocks with strong growth characteristics and buy ranks are highlighted for investors to consider on December 3 Group 1: Micron Technology, Inc. (MU) - Micron Technology is a semiconductor company with a Zacks Rank 1 [1] - The Zacks Consensus Estimate for its current year earnings has increased by 7% over the last 60 days [1] - The company has a PEG ratio of 0.49, significantly lower than the industry average of 1.41 [1] - Micron Technology possesses a Growth Score of A [1] Group 2: Great Lakes Dredge & Dock Corporation (GLDD) - Great Lakes Dredge & Dock Corporation is a dredging services provider with a Zacks Rank 1 [2] - The Zacks Consensus Estimate for its current year earnings has increased by 7.8% over the last 60 days [2] - The company has a PEG ratio of 0.97, compared to the industry average of 2.91 [2] - Great Lakes Dredge & Dock Corporation possesses a Growth Score of A [2] Group 3: Universal Health Services, Inc. (UHS) - Universal Health Services is a healthcare services company with a Zacks Rank 1 [3] - The Zacks Consensus Estimate for its current year earnings has increased by 6.8% over the last 60 days [3] - The company has a PEG ratio of 0.81, which is lower than the industry average of 0.96 [3] - Universal Health Services possesses a Growth Score of B [3]

Core Insights - Three stocks with strong value characteristics and a buy rank are highlighted for investors to consider on December 3 Group 1: Universal Health Services, Inc. (UHS) - UHS has a Zacks Rank of 1, indicating strong performance potential [1] - The Zacks Consensus Estimate for UHS's current year earnings has increased by 6.7% over the last 60 days [1] - UHS has a price-to-earnings (P/E) ratio of 10.97, significantly lower than the industry average of 25.01 [1] - The company possesses a Value Score of A, indicating strong value characteristics [1] Group 2: Oceaneering International, Inc. (OII) - OII also carries a Zacks Rank of 1, suggesting strong investment potential [2] - The Zacks Consensus Estimate for OII's next year earnings has risen by 11.7% over the last 60 days [2] - OII has a P/E ratio of 12.33, which is slightly lower than the industry average of 12.90 [2] - The company possesses a Value Score of A, reflecting its strong value attributes [2] Group 3: WisdomTree, Inc. (WT) - WT holds a Zacks Rank of 1, indicating favorable investment prospects [3] - The Zacks Consensus Estimate for WT's current year earnings has increased by 6.8% over the last 60 days [3] - WT has a P/E ratio of 13.96, compared to the industry average of 25.01, indicating relative undervaluation [3] - The company possesses a Value Score of B, suggesting solid value characteristics [3]

Core Insights - Waterdrop Inc. was awarded the Global Best Case Brands Award for its contributions to inclusive protection and innovative practices in the insurance and healthcare sectors [1][2][7] Company Overview - Founded in 2016, Waterdrop Inc. is a leading insurance technology and healthcare platform in China, focusing on making insurance and healthcare accessible for all [3] - The company's business portfolio includes Waterdrop Medical Crowdfunding, Waterdrop Insurance Marketplace, E-Find, Waterdrop Financial, and Lugo Visa, creating a diversified service ecosystem [3] Technological Advancements - Since 2019, Waterdrop has invested nearly RMB 300 million annually in technology R&D, particularly in AI to enhance insurance offerings [4] - The GuardianShuishou LLM, developed by Waterdrop, has completed algorithm filing and secured multiple patents, with 48 patents related to its foundation model filed by the end of 2024 [4][5] Product Innovation - Waterdrop has launched inclusive insurance products tailored for seniors, individuals with pre-existing conditions, and pregnant women, introducing 214 new offerings in 2025 alone [5] - The company has created products that require no health declaration, with an average of one new product for pre-existing conditions launched every 1.14 days [5] Social Impact - Waterdrop Medical Crowdfunding has facilitated approximately RMB 70 billion in contributions for over 3.54 million patients with major illnesses, with a new fundraising campaign initiated every 53 seconds [6] - The platform allows patients to share campaigns on social networks, enabling quick and easy donations, with an average of seven staff members supporting each campaign [6] Future Outlook - Winning the Global Best Case Brands Award underscores the research value of Waterdrop's innovative business model, with a commitment to deepening its AI-driven strategy and enhancing inclusive protection [7]

Core Insights - The company finished a strong fiscal year 2025, with EPS and adjusted operating income both increasing by 16% [1] - The stock price has appreciated approximately 55% [1] - The company has not experienced a down year in almost 7 years, with a compounded stock price growth of 25% [1] Financial Performance - EPS and adjusted operating income growth of 16% in fiscal year 2025 [1] - Stock price increase of about 55% [1] Investor Sentiment - Investors are questioning whether they have missed the opportunity to invest in the company [1] - The discussion aims to assess the potential for continued growth and investment opportunities [1]

Claritev Corporation (NYSE:CTEV) 2025 Conference December 02, 2025 07:30 AM ET Company ParticipantsDoug Garis - CFOModeratorEveryone, thanks for, I guess, first and foremost, thanks for everyone for joining us at the conference. Really appreciate it. And we especially want to thank, like I said, the management team, starting with the team from Claritev Corporation. Doug Garis, Chief Financial Officer, is with us. Doug, a lot of great things to talk about. I thought maybe we'd just start by a general introdu ...

Core Insights - Aledade, a US-based independent primary care provider network, has secured a $500 million senior secured credit facility from Ares Commercial Finance to support its growth initiatives [1][3] - The credit facility doubles Aledade's existing financing capacity and has the potential to expand to $650 million [1] - Aledade is a participant in the Medicare Shared Savings Program (MSSP), focusing on helping primary care organizations transition to value-based care models [1] Financial Performance - In 2024, Aledade's MSSP Accountable Care Organizations (ACOs) generated savings of $1 billion [2] - The new credit facility will provide Aledade with working capital flexibility to manage expenses and assist partners in transitioning from fee-for-service to value-based care [2] Operational Scope - Aledade collaborates with over 20,000 clinicians across 2,400 practices and community health centers in 46 states, delivering value-based care programs to nearly three million Medicare patients [2] - The CEO of Aledade emphasized that the working capital facility will help bridge the timing gap in Medicare payments and allow for accelerated shared savings distributions to clinician partners [3] Strategic Importance - Ares Commercial Finance expressed enthusiasm in supporting Aledade's growth plans, highlighting the role of Aledade's technology in expanding value-based primary care nationally, benefiting both patients and physicians [3]

CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC ("Monroe†) announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisitions of Reliant Healthcare ("Reliant†) and Care Fusion Rx ("Care Fusion†) by private equity sponsor Shore Capital Partners. Founded in 2008, Reliant is a provider of home infusion and ambulatory infusion center services to patients in the South. Reliant aims to improve the patient experience by offering conven. ...